- Home
- CNXN vs NVAX Comparison
CNXN vs NVAX Comparison
Compare CNXN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNXN
- NVAX
- Stock Information
- Founded
- CNXN 1982
- NVAX 1987
- Country
- CNXN United States
- NVAX United States
- Employees
- CNXN N/A
- NVAX N/A
- Industry
- CNXN Catalog/Specialty Distribution
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNXN Consumer Discretionary
- NVAX Health Care
- Exchange
- CNXN Nasdaq
- NVAX Nasdaq
- Market Cap
- CNXN 1.6B
- NVAX 1.4B
- IPO Year
- CNXN 1998
- NVAX 1995
- Fundamental
- Price
- CNXN $60.97
- NVAX $8.40
- Analyst Decision
- CNXN
- NVAX Hold
- Analyst Count
- CNXN 0
- NVAX 6
- Target Price
- CNXN N/A
- NVAX $11.33
- AVG Volume (30 Days)
- CNXN 74.6K
- NVAX 4.2M
- Earning Date
- CNXN 10-29-2025
- NVAX 11-06-2025
- Dividend Yield
- CNXN 0.98%
- NVAX N/A
- EPS Growth
- CNXN N/A
- NVAX N/A
- EPS
- CNXN 3.24
- NVAX 2.54
- Revenue
- CNXN $2,878,704,000.00
- NVAX $1,078,718,000.00
- Revenue This Year
- CNXN $7.92
- NVAX $61.25
- Revenue Next Year
- CNXN $5.82
- NVAX N/A
- P/E Ratio
- CNXN $18.82
- NVAX $3.30
- Revenue Growth
- CNXN 3.19
- NVAX 9.22
- 52 Week Low
- CNXN $55.50
- NVAX $5.01
- 52 Week High
- CNXN $75.84
- NVAX $11.55
- Technical
- Relative Strength Index (RSI)
- CNXN 46.24
- NVAX 47.30
- Support Level
- CNXN $56.06
- NVAX $8.25
- Resistance Level
- CNXN $62.56
- NVAX $8.66
- Average True Range (ATR)
- CNXN 1.33
- NVAX 0.37
- MACD
- CNXN -0.02
- NVAX -0.04
- Stochastic Oscillator
- CNXN 68.86
- NVAX 28.79
About CNXN PC Connection Inc.
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.